calendar
9,551 catalysts · 9,551 approval
Week of Aug 7, 2006
7Aug 8, 2006approvalRITALIN LA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalRITALIN LA
Sponsor: SANDOZ. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
9,551 catalysts · 9,551 approval
Sponsor: SANDOZ. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: SANDOZ. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: IMPAX LABS INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: AYTU BIOPHARMA. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: APIL. Form: TABLET. Route: ORAL
Sponsor: APIL. Form: TABLET. Route: ORAL
Sponsor: ENDO OPERATIONS. Form: TABLET. Route: ORAL
Sponsor: ANI PHARMS. Form: SYRUP. Route: ORAL
Sponsor: CHEPLAPHARM. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: CHEPLAPHARM. Form: TABLET. Route: ORAL
Sponsor: CHEPLAPHARM. Form: POWDER. Route: INTRAMUSCULAR
Sponsor: AMNEAL PHARMS NY. Form: TABLET. Route: ORAL
Sponsor: AMNEAL PHARMS NY. Form: TABLET. Route: ORAL
Sponsor: PH HEALTH. Form: TABLET. Route: ORAL
Sponsor: CEPHALON. Form: TROCHE/LOZENGE. Route: TRANSMUCOSAL
Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: KENVUE BRANDS. Form: SOLUTION. Route: TOPICAL
Sponsor: SUN PHARM INDS INC. Form: TABLET. Route: ORAL
Sponsor: SANDOZ. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: SCHERING. Form: SUSPENSION. Route: ORAL
Sponsor: SANDOZ. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: IMMUNEX. Form: SYRINGE
Sponsor: CEPHALON. Form: TABLET. Route: BUCCAL, SUBLINGUAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: BAXTER HLTHCARE. Form: LIQUID. Route: INHALATION
Sponsor: PROVEPHARM SAS. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: LABS JUVISE. Form: CAPSULE. Route: ORAL
Sponsor: APOTEX. Form: TABLET. Route: ORAL
Sponsor: ABBVIE. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: LANNETT CO INC. Form: SYRUP. Route: ORAL
Sponsor: ABBVIE. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ABBVIE. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL
Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL